Please login to the form below

Not currently logged in
Email:
Password:

Trobalt

This page shows the latest Trobalt news and features for those working in and with pharma, biotech and healthcare.

GSK/ Valeant's Trobalt set for EU restrictions

GSK/ Valeant's Trobalt set for EU restrictions

European regulatory advisors have recommended GlaxoSmithKline and Valeant's epilepsy drug Trobalt be restricted after safety concerns over its use emerged. ... The CHMP said the move followed cases of abnormal colouring of the skin, nails, lips and eye

Latest news

  • Therapy focus: Epilepsy

    In May 2011, GlaxoSmithKline launched its new epilepsy medicine Trobalt in the UK.

  • FDA approves GSK/Valeant anti-seizure drug

    In the EU, ezogabine is known as retigabine (Trobalt). The drug received marketing authorisation in the EU in March 2011.

  • GSK launches first-in-class epilepsy drug

    GSK introduces Trobalt for the adjunct treatment of adults with partial-onset seizures. ... GlaxoSmithKline (GSK)  has launched Trobalt (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with

  • GSK sales fall for first quarter of 2011

    Recent approvals for GSK include lupus drug Benlysta (belimumab), Horizant (gabapentin enacarbil) for Restless Legs Syndrome and epilepsy treatment Trobalt (retigabine).

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....